News
Kaken assumes ownership of Aadi Sub, including the Aadi Bioscience name, trademarks and the FYARRO® (sirolimus protein-bound particles for injectable suspension) (albumin-bound) business.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback